ATG7 and glioblastoma: Additionally, in vivo experiments showed that bevacizumab-treated GBM cells with shRNA targeting and knocking down autophagy related gene 7 (ATG7), a gene essential for the formation of the autophagosome, exhibited 90% long-term survival 61.